End-of-day quote
Korea S.E.
18:00:00 2024-05-16 EDT
|
5-day change
|
1st Jan Change
|
33,950
KRW
|
+2.72%
|
|
-4.10%
|
+0.59%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
225,466
|
225,208
|
252,646
|
352,385
|
352,385
|
Enterprise Value (EV)
1 |
225,443
|
225,178
|
252,646
|
352,385
|
352,385
|
P/E ratio
|
15
x
|
19.6
x
|
12.2
x
|
13
x
|
9.6
x
|
Yield
|
1.68%
|
1.67%
|
-
|
1.77%
|
1.77%
|
Capitalization / Revenue
|
2.29
x
|
2.03
x
|
-
|
2.29
x
|
1.97
x
|
EV / Revenue
|
2.29
x
|
2.03
x
|
-
|
2.29
x
|
1.97
x
|
EV / EBITDA
|
8.41
x
|
8.15
x
|
-
|
7.05
x
|
5.87
x
|
EV / FCF
|
37.1
x
|
41.4
x
|
-
|
11
x
|
9.79
x
|
FCF Yield
|
2.69%
|
2.42%
|
-
|
9.08%
|
10.2%
|
Price to Book
|
1.88
x
|
1.79
x
|
-
|
2.02
x
|
1.47
x
|
Nbr of stocks (in thousands)
|
9,493
|
9,403
|
9,121
|
10,380
|
10,380
|
Reference price
2 |
23,750
|
23,950
|
27,700
|
33,950
|
33,950
|
Announcement Date
|
21-02-15
|
22-02-07
|
23-03-22
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
98.48
|
111
|
-
|
154
|
179
|
EBITDA
1 |
26.8
|
27.64
|
-
|
50
|
60
|
EBIT
1 |
16.64
|
15.99
|
-
|
40.2
|
47.3
|
Operating Margin
|
16.9%
|
14.41%
|
-
|
26.1%
|
26.42%
|
Earnings before Tax (EBT)
1 |
20.31
|
11.34
|
-
|
36.6
|
51.6
|
Net income
1 |
15.08
|
9.363
|
21.09
|
29.3
|
39.7
|
Net margin
|
15.32%
|
8.44%
|
-
|
19.03%
|
22.17%
|
EPS
2 |
1,587
|
1,224
|
2,274
|
2,607
|
3,537
|
Free Cash Flow
3 |
6,070
|
5,441
|
-
|
32,000
|
36,000
|
FCF margin
|
6,163.92%
|
4,902.38%
|
-
|
20,779.22%
|
20,106.12%
|
FCF Conversion (EBITDA)
|
22,651.18%
|
19,683.42%
|
-
|
64,000%
|
60,000%
|
FCF Conversion (Net income)
|
40,243%
|
58,117.61%
|
-
|
109,215.02%
|
90,680.1%
|
Dividend per Share
2 |
400.0
|
400.0
|
-
|
600.0
|
600.0
|
Announcement Date
|
21-02-15
|
22-02-07
|
23-03-22
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
23.2
|
29.6
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
6,070
|
5,441
|
-
|
32,000
|
36,000
|
ROE (net income / shareholders' equity)
|
13%
|
7.38%
|
-
|
19.5%
|
18.5%
|
ROA (Net income/ Total Assets)
|
9.61%
|
4.77%
|
-
|
13.3%
|
16.7%
|
Assets
2 |
157
|
196.2
|
-
|
220.3
|
237.7
|
Book Value Per Share
3 |
12,633
|
13,399
|
-
|
16,828
|
23,069
|
Cash Flow per Share
3 |
-
|
1,935
|
-
|
3,449
|
4,518
|
Capex
2 |
17.7
|
13.7
|
-
|
2
|
10
|
Capex / Sales
|
17.96%
|
12.38%
|
-
|
1.3%
|
5.59%
|
Announcement Date
|
21-02-15
|
22-02-07
|
23-03-22
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Last Close Price
33,950
KRW Average target price
56,000
KRW Spread / Average Target +64.95% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.59% | 255M | | +32.09% | 694B | | +29.39% | 593B | | -1.34% | 371B | | +20.34% | 331B | | +7.39% | 290B | | +14.25% | 239B | | -3.03% | 209B | | +10.02% | 209B | | +8.49% | 169B |
Other Pharmaceuticals
|